Blog
 » 
Asepsis
 » 
MRSP Prevention Through Proper Asepsis

MRSP Prevention Through Proper Asepsis

Asepsis

X min read

Owners

Learn how proper asepsis prevents MRSP infections in pets with expert veterinary tips and practical steps.

By 

Sustainable Vet Group

Updated on

July 17, 2026

.

This article is for informational purposes only and is not a substitute for professional veterinary advice. Every case is unique, so always consult your veterinarian for guidance specific to your pet.

This content is intended for veterinary professionals for educational purposes. It does not replace clinical judgment or tailored advice. Always rely on your training, expertise, and the specific context of your patients.

MRSP Prevention Through Proper Asepsis

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is the most clinically significant drug-resistant pathogen in veterinary surgical site infections. It cannot be reliably treated with beta-lactam antibiotics, and treatment options when it does occur may be severely limited.

The primary prevention strategy is asepsis. Not antibiotics. Asepsis.

 

What this covers: How MRSP is transmitted in veterinary surgical settings, why asepsis is the primary prevention strategy, the specific asepsis components most relevant to MRSP control, and how MRSP connects to antimicrobial stewardship.Evidence base: Finnish veterinary teaching hospital MRSP outbreak study (PMC4198203); Veterinary Practice News MRSP carrier rate and biofilm data; BMC Veterinary Research skin asepsis protocol study (PMC5852956); MRSP colonization as SSI risk factor in orthopedic surgery cohort studies.Clinical relevance: MRSP carrier rate in dogs is approximately 4.4%. MRSP-colonized dogs have a 14-times higher SSI infection rate. MRSP produces biofilm that resists both antibiotic penetration and host immune response. Once established in a surgical wound, MRSP infection frequently requires implant removal.

 

Key takeaways

  • MRSP carrier rate in dogs is approximately 4.4%; colonized dogs have 14x higher SSI risk.
  • MRSP is transmitted primarily through contact: hands, surfaces, and instruments.
  • Strict asepsis is the most effective MRSP prevention strategy available.
  • MRSP forms biofilm on implants, making established infections extremely difficult to treat.
  • Hand hygiene is the primary barrier to MRSP transmission between patients in clinic settings.
  • Antimicrobial prophylaxis does not reliably prevent MRSP SSI: asepsis does.
  • MRSP outbreaks in veterinary hospitals are documented and can be severe.

What MRSP is and why it matters

Staphylococcus pseudintermedius is a commensal organism of the canine skin, mucous membranes, and anal sacs. In most dogs it causes no harm. In the context of surgery, it is the most frequent bacterial cause of SSI in small animal practice.

MRSP is the methicillin-resistant variant. It carries the mecA gene, which confers resistance to all beta-lactam antibiotics (penicillins, cephalosporins, carbapenems). MRSP strains commonly acquire resistance to additional antibiotic classes, sometimes leaving only a small number of treatment options.

Clinical consequences of MRSP SSI:

  • Infection that does not respond to first-line or commonly used antibiotics
  • Prolonged, expensive treatment courses with agents potentially reserved for human critical care
  • In orthopedic procedures: biofilm formation on implant surfaces that is not penetrable by antibiotics at achievable concentrations
  • Implant removal frequently required to resolve MRSP implant-associated infection
  • Prolonged patient morbidity, owner distress, and reputational consequences for the practice

Veterinary Practice News reports: "The most common pathogen involved in small animal surgical site infections today is MRSP. The overall carrier rate is approximately 4.4%, with a 14 times higher infection rate in part due to its ability to develop a biofilm."

How MRSP is transmitted in veterinary settings

MRSP transmission is contact-mediated. This is the central fact that makes asepsis the primary prevention strategy.

Transmission routes:

  1. Endogenous (patient's own flora): The most common source. MRSP on the dog's skin or in the nasal or anal carriage is introduced into the wound during or after surgery. Skin antisepsis reduces but does not eliminate this risk.

  2. Healthcare worker hands: Hands of veterinary staff colonized with MRSP or contaminated by contact with MRSP-positive patients can transfer MRSP to wounds, instruments, and surfaces. A Finnish MRSP outbreak study (PMC4198203) documented clonal spread of MRSP through a veterinary teaching hospital over 26 months.

  3. Environmental surfaces: MRSP can survive on clinical surfaces (exam tables, kennel surfaces, equipment) long enough to contaminate subsequent patients via staff hands or direct contact. The same Finnish study found the outbreak extended through surgery wards and intensive care.

  4. Instruments and implants: Non-sterile instruments, or instruments whose sterility was compromised during handling, introduce MRSP directly into the wound.

What this means for prevention:

Every component of asepsis addresses one or more of these routes. Skin antisepsis addresses endogenous flora. Hand hygiene addresses the healthcare worker route. Surface disinfection addresses environmental persistence. Instrument sterilization and aseptic technique address direct wound inoculation.

The MRSP outbreak: what happens when asepsis fails

A Finnish veterinary teaching hospital experienced a large MRSP outbreak lasting 26 months (November 2010 to January 2012). The study (PMC4198203) documented:

  • Clonal spread of a multi-drug resistant MRSP strain through the hospital
  • Identified risk factors: skin lesion (OR 6.2), prior antimicrobial treatment (OR 3.8), days in ICU (OR 1.3 per day), days in surgery ward (OR 1.1 per day)
  • The outbreak required: contact tracing, enhanced hand hygiene, cohorting, barrier nursing, enhanced disinfection, and a search-and-isolate policy on admission

The outcome: a search-and-isolate policy at admission, identifying MRSP-positive patients before surgery, was the intervention that eventually controlled the outbreak.

The prevention lesson: The interventions used to control the outbreak: hand hygiene, barrier nursing, enhanced disinfection, isolation, are the same asepsis principles that would have prevented it. An outbreak forces these practices. Routine asepsis compliance maintains them.

MRSP and biofilm: why prevention is non-negotiable

MRSP produces biofilm: a structured community of bacteria enclosed in a self-produced extracellular matrix. Biofilm formation on orthopedic implants (plates, screws) creates a reservoir of infection that:

  • Is physically protected from host immune cell penetration
  • Prevents antibiotics from reaching effective concentrations at the bacteria
  • Cannot be cleared by systemic antibiotic therapy alone
  • Requires removal of the implant (and the biofilm attached to it) to resolve the infection

For TPLO and other implant procedures, the MRSP SSI consequence is not just a prolonged wound infection. It is frequently an infection requiring a second surgery, implant removal, extended convalescence, and in some cases loss of function.

The implication for asepsis: preventing MRSP from entering the wound is infinitely preferable to treating MRSP once it has formed biofilm on an implant. Treatment is difficult. Prevention through asepsis is achievable.

For asepsis during TPLO surgery, including the specific asepsis protocol elements that are most critical for TPLO procedures where MRSP-biofilm risk is highest, that guide covers the TPLO-specific asepsis requirements.

The aseptic technique framework is where all these individual MRSP prevention components come together intraoperatively. For aseptic technique applied to MRSP-risk procedures, including the sterile field rules, instrument handling, double-gloving technique, and OR behavior standards that constitute the intraoperative MRSP prevention protocol, that guide covers the technique framework.

Asepsis components most relevant to MRSP prevention

Skin antisepsis

The BMC Veterinary Research study (PMC5852956) confirmed that both chlorhexidine-alcohol and povidone-iodine skin antisepsis protocols achieved no bacterial growth in 70 to 74% of post-prep samples. The same study found only 4.3% of dogs had methicillin-resistant species detectable pre-operatively on the surgical site.

This means skin antisepsis is highly effective at eliminating most surface MRSP. The residual risk comes from follicular bacteria and from perioperative environmental and instrument contamination.

Surgical hand antisepsis

Healthcare worker hands are a documented MRSP transmission vector. Strict surgical hand antisepsis before every procedure, and hand hygiene between all patient contacts in the clinic, reduces this route.

Zoetis infection control guidance states: "Strict asepsis during surgery including a thorough hand and nail scrubbing with a cleaning and disinfectant agent followed by sterile gowning and gloving is most important in preventing transmission of MRSA/MRSP from the colonized surgeon or assistant to the pet."

Instrument sterilization

MRSP on inadequately sterilized instruments is directly inoculated into the surgical wound. Validated autoclave sterilization with weekly biological indicator testing eliminates this route.

OR traffic control

Personnel entering the OR shed skin cells carrying bacteria including any MRSP they carry. Minimizing OR traffic during implant procedures directly reduces airborne contamination load.

Intraoperative wound lavage

Intraoperative antiseptic lavage before wound closure addresses residual bacterial contamination that accumulated during surgery. Non-antibiotic antiseptic lavage options, such as Simini Protect Lavage, have been used in veterinary orthopedic surgery specifically to reduce bacteria, biofilms, and resistant organisms including MRSP at the wound before suturing.

For breaks in asepsis that allow MRSP contamination, including the specific break categories that create windows for MRSP entry into the surgical wound, that guide covers break identification and response.

MRSP and antimicrobial stewardship

MRSP's resistance pattern makes it directly relevant to antimicrobial stewardship.

Why prophylaxis often fails against MRSP:

Standard perioperative antimicrobial prophylaxis (typically cefazolin or cephalexin) targets susceptible staphylococci. MRSP is resistant to these agents by definition. Prophylaxis that covers susceptible organisms provides no meaningful protection against MRSP SSI.

Veterinary Practice News notes: "Most proposed protocols include using various dosages of cephalexin, with most SSIs involving organisms that are resistant to that drug."

The stewardship implication:

If standard prophylaxis doesn't prevent MRSP SSI, and broadening prophylaxis to agents that do cover MRSP means using antibiotics critical for human medicine (potentially violating stewardship principles), then the primary MRSP prevention strategy must be non-antibiotic.

Asepsis is that strategy.

For asepsis in orthopedic implant surgery, including the full asepsis protocol for procedures where MRSP-biofilm risk is highest, that guide covers the implant-specific asepsis requirements.

MRSP screening and pre-operative risk assessment

For high-risk procedures (TPLO, complex orthopedic reconstruction, revision surgery), pre-operative MRSP screening of the patient allows:

  • Identification of carrier status before surgery
  • Targeted skin decolonization protocols where indicated
  • Informed decision-making about surgical scheduling and isolation precautions
  • Enhanced post-operative monitoring for patients at elevated SSI risk

The Finnish outbreak study implemented admission screening as its primary outbreak control measure. Proactive pre-operative screening for elective high-risk cases applies this principle preventively.

For surgical asepsis standards for high-risk cases, including the full five-domain asepsis framework and how it applies to procedures with elevated MRSP risk, that guide covers the comprehensive asepsis standard.

Frequently asked questions

Can decolonization eliminate MRSP before surgery?

Mupirocin nasal ointment and chlorhexidine body wash protocols have been used in human medicine to decolonize MRSA carriers before elective surgery, with documented reduction in SSI rates. Equivalent veterinary protocols are less well-established, but chlorhexidine-based skin preparation in the weeks before surgery has been proposed for MRSP-positive dogs undergoing elective procedures. Consult current veterinary dermatology guidelines for specific decolonization protocols.

If MRSP SSI is so difficult to treat, why not use broader prophylaxis?

Broadening prophylaxis to agents that cover MRSP (such as vancomycin equivalents) uses antibiotics classified as critically important for human medicine. Using these agents prophylactically in veterinary patients contributes to resistance development in organisms that cross between animals and humans. This is the core stewardship dilemma: the antibiotic that would prevent MRSP SSI is the one that should be preserved for treatment of serious human infections. Asepsis resolves this dilemma by preventing the SSI without antibiotics.

Does MRSP pose a zoonotic risk to veterinary staff?

MRSP can colonize humans, particularly those in close contact with dogs. Veterinary staff who work with MRSP-positive patients or in practices with ongoing MRSP transmission have demonstrated higher colonization rates. This is an occupational health concern as well as a patient safety issue. The same hand hygiene and barrier precautions that protect patients also protect staff.

MRSP is the argument for asepsis that antibiotics cannot make. When the pathogen is resistant to the antibiotics available and forms biofilm that resists both antibiotic penetration and immune response, the only strategy that reliably prevents infection is the one that prevents the organism from entering the wound in the first place. That strategy is asepsis.

Resources

The following sources were used as reference and background for this article:

  • NIH/PMC. Large Outbreak Caused by MRSP ST71 in a Finnish Veterinary Teaching Hospital. ncbi.nlm.nih.gov
  • Veterinary Practice News. Old and New Thoughts on Infection Control. veterinarypracticenews.com
  • NIH/PMC. Skin asepsis protocols as a preventive measure of SSI in dogs: chlorhexidine-alcohol versus povidone-iodine. ncbi.nlm.nih.gov
  • Zoetis Canada. Controlling Methicillin Resistant Staphylococcus Infection Control Strategies for Veterinary Hospitals. zoetis.ca
  • CAVD. What is Methicillin-resistant Staphylococcus Pseudintermedius? wormsandgermsblog.com

Get a Free Poster

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

Things to know

Get a Free Poster for Your Clinic

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

We'd love you to
Join Us!

Enter Your Details Below to Receive Your Information Pack

100% safe & secure. Your details are never shared or sold.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Taking Great TPLO Radiographs

Click Below to Watch Live Video Demos

We'll send you a Free Wall Poster with all the steps

Now that you are a pro at TPLO rads

Let's take your infection control to the next level

Watch these videos!

Step #1

Getting Ready

Ensuring a clean surgical field starts with proper skin preparation. This video demonstrates the best practices for:

  • Shaving the patient – Achieving a close, even shave while minimizing skin irritation
  • The Dirty Scrub – The initial skin prep step to remove surface debris and reduce bacterial load before the sterile scrub.

Following these techniques helps reduce infection risk and improve surgical outcomes. Watch the video to see how it’s done effectively!

Step #2

Reduce Your Risks

Many surgeons are shocked to find out that their patients are not protected from biofilms and resistant bacteria when they use saline and post-op antibiotics.

That’s Where Simini Comes In.

Why leave these risks and unmanaged?  Just apply Simini Protect Lavage for one minute. Biofilms and resistant bacteria can be removed, and you can reduce two significant sources of infection.

Step #3

Take the Course

Preventing surgical infections is critical for patient safety and successful outcomes. This course covers:

  • Aseptic techniques – Best practices to maintain a sterile field.
  • ​Skin prep & draping – Proper methods to minimize contamination.
  • ​Antibiotic stewardship – When and how to use perioperative antibiotics effectively.

Stay up to date with the latest evidence-based protocols. Click the link to start learning and earn CE credits!

Get Your
Free Poster!

Enter your information below, and we’ll ship it to you at no cost.

Do you want to customize it?

How many would you like?

About you

Shipping information

100% safe & secure. Your details are never shared or sold.

We will work on your request shortly.
Oops! Something went wrong while submitting the form.
What’s your role in animal care?

Tell us who you are so we can guide you to the most relevant information.